Search results
Abiomed (ABMD) Q2 Earnings Top Estimates, Margins Down
Zacks via Yahoo Finance· 2 years agoAbiomed, Inc. ABMD delivered adjusted earnings per share (EPS) of $1.30 in the second quarter of...
Abiomed (ABMD) Earnings Expected to Grow: Should You Buy?
Zacks via Yahoo Finance· 2 years agoAbiomed (ABMD) possesses the right combination of the two key ingredients for a likely earnings beat...
Abiomed (ABMD) Q1 Earnings Top Estimates
Zacks via Yahoo Finance· 2 years agoAbiomed (ABMD) delivered earnings and revenue surprises of 15.74% and 0.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to...
Why Abiomed Stock Skyrocketed Today
Motley Fool· 2 years agoShares of Abiomed (NASDAQ: ABMD) soared 50% on Tuesday after the medical device maker struck an acquisition deal with Johnson & Johnson (NYSE: JNJ). J&J...
3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio
Zacks via Yahoo Finance· 1 year agoAbiomed, Inc. ABMD is well-poised for growth in the coming quarters, backed by strength in its...
J&J to buy heart pump maker Abiomed for $16.6 billion ahead of consumer health spinoff
Reuters via Yahoo Finance· 2 years ago(Reuters) -Johnson & Johnson said on Tuesday it struck a deal to buy heart pump maker Abiomed Inc...
Abiomed Shares Pop 50% on Johnson & Johnson Buyout
GuruFocus.com via Yahoo Finance· 2 years agoMarking its biggest deal in nearly six years, Johnson & Johnson (NYSE:JNJ) announced on Tuesday it is buying Abiomed Inc. (NASDAQ:ABMD) for $16.6 billion...
Should You Investigate Abiomed, Inc. (NASDAQ:ABMD) At US$292?
Simply Wall St. via Yahoo Finance· 2 years agoToday we're going to take a look at the well-established Abiomed, Inc. (NASDAQ:ABMD). The company's...
ABIOMED, Inc. (ABMD) Soars to 52-Week High, Time to Cash Out?
Zacks via Yahoo Finance· 2 years agoShares of Abiomed (ABMD) have been strong performers lately, with the stock up 43.1% over the past...
Abiomed (ABMD) Posts Impellas Positive Study Results in Japan
Zacks via Yahoo Finance· 2 years agoAbiomed, Inc. ABMD recently announced the result of a three-year, investigator-led study of all...